TATE JEFFREY

Chief Operating Officer

OtherM

US·SEC (Form 4)

Cyclo Therapeutics, Inc.

0

Total declarations

0

Company

€7,598

▲ Purchases (2 ops.)

—

▼ Sales (0 ops.)

Explore the complete record of transactions filed by TATE JEFFREY, Chief Operating Officer. Director active across 1 companies, notably Cyclo Therapeutics, Inc.. Cumulatively, 2 reports have been published. Total volume traded: €8k. The latest transaction was disclosed on 16 May 2022 — Acquisition. Regulator: SEC (Form 4). All data is free.

Declarations2 total

Executives▲PurchaseCCyclo Therapeutics, Inc.37SEC

T

TATE JEFFREYChief Operating Officer

€6,0873,000 shares@ €2.028980.1% of flow

Common Stock

SEC:0001437749-22-012531:0·16 May 2022

Ideal exit: 10 Feb 2023 (T+270)

SEC ↗

Executives▲PurchaseCCyclo Therapeutics, Inc.32SEC

T

TATE JEFFREYChief Operating Officer

€1,511635 shares@ €2.3819.9% of flow

Common Stock

SEC:0001437749-22-010226:0·28 Apr 2022

Ideal exit: 23 Jan 2023 (T+270)

SEC ↗

2 of 2 declarations

About TATE JEFFREY

Jeffrey Tate is the Chief Operating Officer at Cyclo Therapeutics, Inc. He is responsible for managing the daily operations of the company, ensuring efficiency and optimization of operational processes.